Journal profile · GERIATRICS & GERONTOLOGY-IMMUNOLOGY
Immunity & Ageing
ISSN 1742-4933 · BioMed Central · ENGLAND · Founded 2004
Immunity & Ageing: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 8.28; fully open access; APC about USD 3,390; median 76 days to acceptance (95 articles, last 24 months); 61 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Immunity & Ageing is published by BioMed Central and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are T-cell and B-cell Immunology, Neuroinflammation and Neurodegeneration Mechanisms and Immune Cell Function and Interaction, together about 24.9% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
The increasing realization that immune ageing and organismal ageing are intimately inter-related puts the immune system at centre-stage in our efforts to understand and manipulate the ageing process in adult organisms. Immunity & Ageing provides a specific conduit for dissemination of new knowledge in this increasingly important arena. Published since 2004, the journal is a specialist open access journal dedicated to promulgating information on the impact of ageing on human and animal immune systems, the influence of aged immune systems on organismal well-being and longevity, the immune etiology of age-associated diseases and potential immune interventions to increase health span. Immunity & Ageing welcomes submissions dealing with any aspect of ageing in human and model organisms that relates to immune function. Immunity & Ageing will not consider papers dealing with any aspect of ageing that does not include a substantial immunological element, or work solely reporting in silico analyses of publicly-available data. Unsolicited reviews may be considered if presented by authors active in the field being reviewed, but contacting the editors before submission is preferred.
From the journal's Aims & Scope
Research area (LetPub): GERIATRICS & GERONTOLOGY-IMMUNOLOGY
Editor-in-chief Daniela FrascaPublisher website
Editorial board by country: 1 in mainland China (about 3%); most named United States 14, United Kingdom 3, Italy 3, France 2, Canada 2 (31 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- T-cell and B-cell ImmunologyImmunology and Microbiology11.4%
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience6.8%
- Immune Cell Function and InteractionImmunology and Microbiology6.7%
- Immune responses and vaccinationsImmunology and Microbiology6.5%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine5.4%
- Cytomegalovirus and herpesvirus researchMedicine5%
- Neutrophil, Myeloperoxidase and Oxidative MechanismsImmunology and Microbiology4.5%
- Immune Response and InflammationImmunology and Microbiology4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Geriatrics & Gerontology | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Geriatrics & Gerontology | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Geriatrics & Gerontology | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 8.28LetPub ·
- Impact factor (publisher) 2025
- 8.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 7.9Publisher website ·
- CiteScore 2026-06
- 10.9LetPub ·
- SJR 2026-06
- 2.3LetPub ·
- SNIP 2026-06
- 1.4LetPub ·
- h-index
- 38LetPub ·
- h-index
- 82OpenAlex ·
- i10-index
- 527OpenAlex ·
- 2-year mean citedness
- 9.01OpenAlex ·
- Self-citation rate
- 2.4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 61LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 1,000,000Publisher website ·
Articles by year OpenAlex count · 776 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 48 | 48 | 13 |
| 2025 | 61 | 61 | 486 |
| 2024 | 90 | 90 | 1,294 |
| 2023 | 76 | 76 | 2,042 |
| 2022 | 67 | 67 | 1,746 |
| 2021 | 45 | 45 | 1,660 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
76 daysMedian, submission to acceptance · P25–P75 49 days – 113 days
- Acceptance to online
- median 15 days (95 articles)
- Submission to online
- median 91 days
- Sample
- 95 articles with submission and acceptance dates (133 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,890 / USD 3,390 / GBP 2,590 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 3,190 / EUR 2,690 / GBP 2,390 | — | — | |
| LetPub | GBP 2,290 / USD 3,090 / EUR 2,590 | Yes | — | |
| Publisher website | GBP 2,590 / USD 3,390 / EUR 2,890 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Suggested reviewers
- Optional
Article types accepted5
- brief reportsResearch articles Reviews Comment Correspondence Brief ReportsLength not stated
- commentResearch articles Reviews Comment Correspondence Brief ReportsLength not stated
- correspondenceResearch articles Reviews Comment Correspondence Brief ReportsLength not stated
- research articlesResearch articles Reviews Comment Correspondence Brief ReportsLength not stated
- reviewsResearch articles Reviews Comment Correspondence Brief ReportsLength not stated
Policy excerpts from the journal's websiteData availability, License & copyright, Open access, Peer review
- Data availability Formatting the 'Availability of data and materials' section of your manuscript
The following format for the 'Availability of data and materials section of your manuscript should be used:
Source ↗Publisher website ·- License & copyright Licensing and copyright
Open access articles published under CC BY-NC-ND or CC BY licences; authors retain copyright. Model summary
Creative Commons licences Open access articles in Springer Nature journals are published under Creative Commons licences. These provide an industry-standard framework to support easy re-use of open access material. Under Creative Commons licences, authors retain copyright of their articles. Immunity & Ageing articles are published open access under a CC BY-NC-ND (Creative Commons Attribution Non-C…
Source ↗Publisher website ·- Open access Benefits of open access
Publishing open access (OA) offers a number of benefits, including greater reach and readership for your work: Cited more 1.6x more citations of OA articles than non-OA articles across all subjects Downloaded more 4x more downloads of OA articles than non-OA articles Greater impact 2.5x more Altmetric attention. OA articles attracted 1.9x more news mentions and 1.2x more policy mentions Open acces…
Source ↗Publisher website ·- Peer review Peer review policy
Peer review is the process used to evaluate the quality of a manuscript before publication. Independent researchers in the relevant field assess submitted manuscripts to check their validity and robustness. Their feedback guides editors in making publication decisions. Typically, two or more experts evaluate each manuscript based on three main criteria: scientific robustness: is the research metho…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BioMed Central
- Country or region
- ENGLAND
- Language
- English
- Founded
- 2004
- ISSN
- 1742-4933
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Immunity & Ageing
What CAS zone is Immunity & Ageing in?
In the 2025 upgraded edition of the CAS Journal Ranking, Immunity & Ageing is in Zone 2 of Medicine, and in Zone 2 of the minor category Geriatrics & Gerontology / Immunology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Immunity & Ageing?
The latest impact factor listed by LetPub is 8.28; CiteScore 10.9, h-index 82.
How long does peer review take at Immunity & Ageing?
Based on the dates recorded on 95 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 76 days (interquartile range 49–113 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Immunity & Ageing based?
Of the 31 board members whose country the journal's board page names, 1 (about 3%) are in mainland China; the countries named most often are United States (14), United Kingdom (3) and Italy (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Immunity & Ageing?
According to LetPub and DOAJ records, Immunity & Ageing is indexed in SCIE, Scopus and DOAJ. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Immunity & Ageing open access, and what is the APC?
Immunity & Ageing is a fully open-access journal. APC about USD 3,390.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .